GenMark Diagnostics, Inc. (GNMK) Financial Statements (2026 and earlier)

Company Profile

Business Address 5964 LA PLACE COURT
CARLSBAD, CA 92008
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:53,46045,16871,99041,56645,46571,000
Cash and cash equivalent44,36036,28626,75415,95935,38536,855
Short-term investments 9,1008,88245,23625,60710,08033,651
Other undisclosed cash, cash equivalents, and short-term investments     494
Receivables16,75911,53410,6769,0486,8474,889
Inventory, net of allowances, customer advances and progress billings11,30110,24410,9496,6333,0542,137
Inventory11,30110,24410,9496,6333,0542,137
Prepaid expense 1,8771,4831,7921,202591575
Other undisclosed current assets     (494)
Total current assets:83,39768,42995,40758,44955,95778,107
Noncurrent Assets
Operating lease, right-of-use asset ✕✕✕✕✕
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization20,41921,07022,58118,26811,39611,052
Intangible asset, including goodwill, after accumulated amortization1,4322,0232,6242,6702,3761,870
Intangible asset, excluding goodwill, after accumulated amortization1,4322,0232,6242,6702,3761,870
Restricted cash and investments 758758758758758
Other noncurrent assets825701192179180183
Other undisclosed noncurrent assets 5,400     
Total noncurrent assets:28,07624,55226,15521,87514,71013,863
TOTAL ASSETS:111,47392,981121,56280,32470,66791,970
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,2499,88611,17114,3538,2378,640
Employee-related liabilities   5,6503,8615,172
Accounts payable12,2499,88611,1718,7034,3763,468
Debt   7,9277,935373 
Other liabilities2,7323,0433,2264,1332,3523,653
Other undisclosed current liabilities9,3357,3585,419 (373) 
Total current liabilities:24,31620,28727,74326,42110,58912,293
Noncurrent Liabilities
Long-term debt and lease obligation69,14536,04220,09911,8809,890 
Long-term debt, excluding current maturities69,14536,04220,09911,8809,890 
Liabilities, other than long-term debt 2,9963,0593,8721,5911,653
Deferred revenue and credits✕✕2,9963,0593,6521,2571,445
Other liabilities   220334208
Operating lease, liability ✕✕✕✕✕
Other undisclosed noncurrent liabilities (69,092)(38,929)(22,917)   
Total noncurrent liabilities:5310924115,75211,4811,653
Other undisclosed liabilities 74,94139,03823,158   
Total liabilities:99,31059,43451,14242,17322,07013,946
Equity
Equity, attributable to parent12,16333,54770,42038,15148,59778,024
Common stock666444
Additional paid in capital526,294500,344487,525393,322353,233340,502
Accumulated other comprehensive income (loss)968099529(10)
Accumulated deficit(514,233)(466,883)(417,120)(355,270)(304,669)(262,472)
Total equity:12,16333,54770,42038,15148,59778,024
TOTAL LIABILITIES AND EQUITY:111,47392,981121,56280,32470,66791,970

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues88,02170,75952,51949,27439,41130,594
Revenue, net✕✕70,48152,26048,91439,02930,328
Cost of revenue(59,418)(51,278)(32,514)(19,700)(15,317)(13,127)
Gross profit:28,60319,48120,00529,57424,09417,467
Operating expenses(70,417)(67,253)(79,522)(78,555)(65,629)(56,521)
Operating loss:(41,814)(47,772)(59,517)(48,981)(41,535)(39,054)
Nonoperating income (expense)(5,472)(2,589)(2,232)(1,520)(622)218
Other nonoperating income (expense)(23)(192)249(160)133(6)
Interest and debt expense(5,961)(3,108)(3,042)(1,536)(880)(20)
Other undisclosed income from continuing operations before equity method investments, income taxes5,9613,1083,0421,53688020
Loss from continuing operations before income taxes:(47,286)(50,361)(61,749)(50,501)(42,157)(38,836)
Income tax expense (benefit)(64)(139)(101)(100)(40)573
Loss from continuing operations:(47,350)(50,500)(61,850)(50,601)(42,197)(38,263)
Loss before gain (loss) on sale of properties:(47,350)(50,500)(61,850)(50,601)(42,197)(38,263)
Net loss available to common stockholders, diluted:(47,350)(50,500)(61,850)(50,601)(42,197)(38,263)

Comprehensive Income ($ in thousands)
Annual | Quarterly

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(47,350)(50,500)(61,850)(50,601)(42,197)(38,263)
Other comprehensive income (loss)1671(86)(50,535)  
Comprehensive loss:(47,334)(50,429)(61,936)(101,136)(42,197)(38,263)
Other undisclosed comprehensive loss, net of tax, attributable to parent     (39)(20)
Comprehensive loss, net of tax, attributable to parent:(47,334)(50,429)(61,936)(101,136)(42,236)(38,283)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: